DE60322371D1 - Volumensparende arzneiform zur kontrollierten freisetzung - Google Patents
Volumensparende arzneiform zur kontrollierten freisetzungInfo
- Publication number
- DE60322371D1 DE60322371D1 DE60322371T DE60322371T DE60322371D1 DE 60322371 D1 DE60322371 D1 DE 60322371D1 DE 60322371 T DE60322371 T DE 60322371T DE 60322371 T DE60322371 T DE 60322371T DE 60322371 D1 DE60322371 D1 DE 60322371D1
- Authority
- DE
- Germany
- Prior art keywords
- active agent
- layer
- membrane system
- controlled release
- dosage form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36871402P | 2002-03-29 | 2002-03-29 | |
US40406102P | 2002-08-16 | 2002-08-16 | |
PCT/US2003/009487 WO2003082207A2 (en) | 2002-03-29 | 2003-03-28 | Volume efficient controlled release dosage form |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60322371D1 true DE60322371D1 (de) | 2008-09-04 |
Family
ID=28678251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60322371T Expired - Fee Related DE60322371D1 (de) | 2002-03-29 | 2003-03-28 | Volumensparende arzneiform zur kontrollierten freisetzung |
Country Status (8)
Country | Link |
---|---|
US (2) | US20030185888A1 (de) |
EP (1) | EP1499289B1 (de) |
JP (1) | JP2005521706A (de) |
AT (1) | ATE401860T1 (de) |
AU (1) | AU2003224794A1 (de) |
CA (1) | CA2481236A1 (de) |
DE (1) | DE60322371D1 (de) |
WO (1) | WO2003082207A2 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
AR039744A1 (es) * | 2002-06-26 | 2005-03-09 | Alza Corp | Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada |
US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
CA2564227A1 (en) * | 2003-09-02 | 2005-03-10 | Alza Corporation | Novel drug compositions and dosage forms of topiramate |
CA2545834A1 (en) * | 2003-11-14 | 2005-06-02 | Alza Corporation | Controlled release of topiramate in liquid dosage forms |
CN1997372B (zh) * | 2004-06-24 | 2010-06-02 | 西梯茜生命工学股份有限公司 | 包含依他康那唑的固态分散剂的制造方法及其医药组成物 |
WO2006007354A2 (en) * | 2004-06-28 | 2006-01-19 | Alza Corporation | A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device |
US7772182B2 (en) * | 2004-08-05 | 2010-08-10 | Alza Corporation | Stable suspension formulations of erythropoietin receptor agonists |
AU2006275718B8 (en) * | 2005-07-28 | 2012-11-01 | Takeda Pharmaceutical Company Limited | Pharmaceutical formulations/composition of guanfacine suitable for single dose form adminstration daily |
US20070098796A1 (en) | 2005-10-31 | 2007-05-03 | Rekhi Gurvinder S | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochrloride |
US20070098791A1 (en) * | 2005-10-31 | 2007-05-03 | Rekhi Gurvinder S | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride |
US8795721B2 (en) * | 2006-12-18 | 2014-08-05 | Eatlittle Inc. | Device for delivery of a substance |
ES2692437T3 (es) * | 2007-08-13 | 2018-12-03 | Abuse Deterrent Pharmaceutical Llc | Fármacos resistentes al abuso, método de uso y método de preparación |
US20090148532A1 (en) * | 2007-12-06 | 2009-06-11 | Venkatesh Gopi M | Preparation of controlled release skeletal muscle relaxant dosage forms |
AU2009223061B2 (en) | 2008-03-11 | 2014-10-09 | Depomed Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
US8372432B2 (en) | 2008-03-11 | 2013-02-12 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
WO2010015840A1 (en) * | 2008-08-08 | 2010-02-11 | Cipla Limited | Osmotic delivery device with modified release |
EP2405754A4 (de) * | 2009-03-09 | 2015-10-14 | Relmada Therapeutics Inc | Pharmazeutische buprenorphin-zusammensetzungen mit modifizierter freisetzung |
CN101856339A (zh) * | 2009-04-09 | 2010-10-13 | 广州柏赛罗药业有限公司 | 一种控释制剂及其制备方法 |
EP3132793A1 (de) | 2009-12-02 | 2017-02-22 | Adamas Pharmaceuticals, Inc. | Amantadinzusammensetzungen und verfahren zur verwendung |
US9198861B2 (en) | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
US8597681B2 (en) | 2009-12-22 | 2013-12-03 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
GB2479213B (en) | 2010-04-01 | 2013-07-10 | Theravida Inc | Pharmaceutical formulations for the treatment of overactive bladder |
US8658631B1 (en) | 2011-05-17 | 2014-02-25 | Mallinckrodt Llc | Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia |
US8741885B1 (en) | 2011-05-17 | 2014-06-03 | Mallinckrodt Llc | Gastric retentive extended release pharmaceutical compositions |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
US20130220349A1 (en) * | 2012-02-23 | 2013-08-29 | Celanese Acetate Llc | Deformable tablet with water triggered catalyst release |
WO2014059309A1 (en) * | 2012-10-11 | 2014-04-17 | Theravida, Inc. | Pharmaceutical formulations of pilocarpine |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
WO2014204933A1 (en) | 2013-06-17 | 2014-12-24 | Adamas Pharmaceuticals, Inc. | Amantadine compositions and methods of use |
CN108697688A (zh) | 2016-01-20 | 2018-10-23 | 塞拉维达公司 | 用于治疗多汗症的方法和组合物 |
US11964048B2 (en) * | 2020-12-18 | 2024-04-23 | Amneal Complex Products Research Llc | Sustained release compositions comprising liothyronine |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
US4058122A (en) * | 1976-02-02 | 1977-11-15 | Alza Corporation | Osmotic system with laminated wall formed of different materials |
US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US4014334A (en) * | 1976-02-02 | 1977-03-29 | Alza Corporation | Laminated osmotic system for dispensing beneficial agent |
US4063064A (en) * | 1976-02-23 | 1977-12-13 | Coherent Radiation | Apparatus for tracking moving workpiece by a laser beam |
US4160452A (en) * | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4285987A (en) * | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
US5190765A (en) * | 1991-06-27 | 1993-03-02 | Alza Corporation | Therapy delayed |
US5160744A (en) * | 1991-06-27 | 1992-11-03 | Alza Corporation | Verapmil therapy |
US5869078A (en) * | 1996-04-25 | 1999-02-09 | Medtronic Inc. | Implantable variable permeability drug infusion techniques |
US6245357B1 (en) * | 1998-03-06 | 2001-06-12 | Alza Corporation | Extended release dosage form |
IL142807A0 (en) * | 1998-11-02 | 2002-03-10 | Alza Corp | Controlled delivery of active agents |
-
2003
- 2003-03-28 EP EP03721484A patent/EP1499289B1/de not_active Expired - Lifetime
- 2003-03-28 JP JP2003579750A patent/JP2005521706A/ja not_active Withdrawn
- 2003-03-28 WO PCT/US2003/009487 patent/WO2003082207A2/en active Application Filing
- 2003-03-28 CA CA002481236A patent/CA2481236A1/en not_active Abandoned
- 2003-03-28 DE DE60322371T patent/DE60322371D1/de not_active Expired - Fee Related
- 2003-03-28 AT AT03721484T patent/ATE401860T1/de not_active IP Right Cessation
- 2003-03-28 AU AU2003224794A patent/AU2003224794A1/en not_active Abandoned
- 2003-03-31 US US10/404,166 patent/US20030185888A1/en not_active Abandoned
-
2007
- 2007-03-12 US US11/684,821 patent/US20070184112A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2481236A1 (en) | 2003-10-09 |
US20070184112A1 (en) | 2007-08-09 |
AU2003224794A8 (en) | 2003-10-13 |
US20030185888A1 (en) | 2003-10-02 |
WO2003082207A2 (en) | 2003-10-09 |
AU2003224794A1 (en) | 2003-10-13 |
JP2005521706A (ja) | 2005-07-21 |
ATE401860T1 (de) | 2008-08-15 |
WO2003082207A3 (en) | 2004-05-13 |
EP1499289B1 (de) | 2008-07-23 |
EP1499289A2 (de) | 2005-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60322371D1 (de) | Volumensparende arzneiform zur kontrollierten freisetzung | |
AR048185A1 (es) | Sistema de entrega de farmacos constituido por uno o mas compartimentos, que comprende un compuesto progestagenico disuelto en un copolimero de polietileno acetato de vinilo termoplastico | |
ES2557988T3 (es) | Método para tratar enfermedades de próstata basado en el suministro local de principios activos | |
NL2000281A1 (nl) | Vaste farmaceutische samenstellingen die pregabaline bevatten. | |
BRPI0415505A (pt) | agente terapêutico para mesotelioma | |
WO2005097064A3 (en) | Taste-masked drugs in rupturing multiparticulates | |
CL2010000188A1 (es) | Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso. | |
EA200400966A1 (ru) | Новые лекарственные формы замещенного бензимидазола и способ их применения | |
AR053541A1 (es) | Combinacion de xolair con agente inmunosupresor | |
AR072075A2 (es) | Un metodo para producir un lente antimicrobiano que comprende una sal metalica | |
BRPI0409652A (pt) | tablete, embalagem farmacêutica, método de tratamento de doenças, e, método de preparação de um tablete | |
IS6102A (is) | Fljótleysanleg skammtaform sem innihalda gelatín úr fiski | |
RU2004134728A (ru) | Дозированные формы и композиции для осмотической доставки различных дозировок оксикодона | |
ATE374601T1 (de) | Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte peptid- oder protein- wirkstoffe, sowie ein verfahren zur herstellung der arzneiform | |
DE60205749D1 (de) | Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe | |
WO2006030402A3 (en) | Dual compartment osmotic delivery device | |
AR061047A1 (es) | Comprimido bicapa para la prevencion de los accidentes cardiovasculares, su uso, y metodo para la prevencion de accidentes cardiovasculares | |
BRPI0513295A (pt) | sistema de distribuição e método para controlar a liberação de pelo menos um agente terapeuticamente ativo a partir do mesmo | |
CL2012000374A1 (es) | Metodo para la preparacion de una composicion saborizante activa que comprende una primera reaccion entre un compuesto amino y un carbonilo, resultando una primera mezcla de intermediarios, una segunda reaccion con un segundo compuesto amino solo o en combinacion con un compuesto carbinilo, resultando una segunda mezcla de intermediarios, reacciones serparadas adicionales con compuestos de otras clases quimicas, ultima reaccion que comprende una mezcla de todas las mezclas de intermediarios anteriores. | |
PE20080400A1 (es) | Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas | |
SE0200895D0 (sv) | New pharmaceutical composition | |
RU2007122391A (ru) | S-миртазапин для лечения приливов | |
AR065342A1 (es) | Composiciones farmaceuticas que contienen fumarato de quetiapina | |
DE50309402D1 (de) | Dentales Formteil, insbesondere künstlicher Zahn | |
CL2004000983A1 (es) | Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |